Cargando…
S6.2b In vitro susceptibility testing of dermatophytes: toward standardization
S6.2 RESURGENCE OF DERMATOPHYTIC INFECTIONS, SEPTEMBER 22, 2022, 4:45 PM - 6:15 PM: Antifungal treatment-resistant dermatophytosis has been known for years(1). It has mainly been reported as sporadic cases with clinical failure to a specific antifungal confirmed by in vitro resistance to antifungal...
Autores principales: | Marie, Ditte, Saunte, Lindhardt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516189/ http://dx.doi.org/10.1093/mmy/myac072.S6.2b |
Ejemplares similares
-
A Review of Antifungal Susceptibility Testing for Dermatophyte Fungi and It’s Correlation with Previous Exposure and Clinical Responses
por: Khan, Sidra Saleem, et al.
Publicado: (2022) -
Disinfection trials with terbinafine‐susceptible and terbinafine‐resistant dermatophytes
por: Skaastrup, Kristoffer Nagy, et al.
Publicado: (2022) -
P107 Spectrum of Dermatophyte infections and drug susceptibility pattern of Dermatophytes in patients visiting to tertiary care hospital in Chhattisgarh state of India
por: Keche, Archana, et al.
Publicado: (2022) -
P087 A clinicomycological study of dermatophyte infection including antifungal susceptibility testing in patients attending a tertiary care hospital in north-western state of rajasthan
por: Charan, Manisha, et al.
Publicado: (2022) -
P121 Effect of corticosteroids on the host innate immune response and in vitro growth characters during dermatophyte infection.
por: Sharma, Arunima, et al.
Publicado: (2022)